Skip to main content

Table 1 Endpoints.

From: Rituximab is effective in the treatment of nephritis in lupus patients, refractory to conventional immunosuppressive therapy

  Baseline 24th weeks Final Visit
Urinary Sediment (%) 37 9.5** 2.2*
24-hour urine protein (gr/24h) 1.2 ± 2.01 0.34 ± 0.58** 0.22 ± 0.38**
C3 (mg/dl) 78.17 ± 31.08 91.3 ± 31.4** 101.4 ± 30.8*
C4 (mg/dl) 12.52 ± 7.95 16.31 ± 7.51** 19.16 ± 8.74*
Anti-DNA (UI) 34.6 (4.85-70.07) 26.1 (2.12-52.5) 13 (3.9-34)**
SLEDAI 14.5 (7.75-22.25) 4 (2-6)* 2 (0-4)*
Physician´s Global Assessment (PGA) 2.75 (2.0-3.0) 0.0 (0.0-1.0)* 0.0 (0.0-1.0)*
  1. *p < 0,0005 respect to baseline.
  2. **p < 0.05 respect to baseline.